Cargando…

Intravitreal Ozurdex has no short term influence on choroidal thickness and vascularity index in eyes with diabetic macular edema: A pilot study

AIM: To analyze choroidal parameters in eyes with diabetic macular edema (DME) treated with intravitreal Ozurdex. PATIENTS AND METHODS: Twenty eyes of 14 patients were included in this prospective study. Optical coherence tomography images were obtained before and 8–10 weeks after intravitreal Ozurd...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rishi, Pukhraj, Verma, Aditya, Akhtar, Zeeshan, Agrawal, Rupesh, Agrawal, Ashutosh, Kalluri Bharat, Rekha Priya, Rishi, Ekta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597814/ https://www.ncbi.nlm.nih.gov/pubmed/34880580 http://dx.doi.org/10.4103/ojo.ojo_7_21

Ejemplares similares

Short-term results of intravitreal dexamethasone implant (OZURDEX(®)) in treatment of recalcitrant diabetic macular edema: A case series
por: Rishi, Pukhraj, et al.
Publicado: (2012)

Analysis of choroidal structure and vascularity indices with image binarization of swept source optical coherence tomography images: A prospective study of 460 eyes
por: Rishi, Pukhraj, et al.
Publicado: (2022)

Fractured Ozurdex™ implant in the vitreous cavity
por: Rishi, Pukhraj, et al.
Publicado: (2012)

Intravitreal bevacizumab for treatment of choroidal neovascularization associated with osteogenesis imperfecta
por: Rishi, Pukhraj, et al.
Publicado: (2012)

Intravitreal bevacizumab for choroidal neovascular membrane associated with Best's vitelliform dystrophy
por: Rishi, Ekta, et al.
Publicado: (2010)

Real-world experience with pro re nata dosing of intravitreal dexamethasone implant for eyes with refractory diabetic macular edema
por: Rishi, Pukhraj, et al.
Publicado: (2020)

Analysis of Potential Ischemic Effect of Intravitreal Bevacizumab on Unaffected Retina in Treatment-Naïve Macular Edema Due to Branch Retinal Vein Occlusion: A Prospective, Interventional Case-Series
por: Rishi, Pukhraj, et al.
Publicado: (2016)

Intravitreal Dexamethasone Implant (Ozurdex) for Refractory Macular Edema Secondary to Retinitis Pigmentosa
por: Örnek, Nurgül, et al.
Publicado: (2016)

Management of peripheral polypoidal choroidal vasculopathy with intravitreal bevacizumab and indocyanine green angiography-guided laser photocoagulation
por: Rishi, Pukhraj, et al.
Publicado: (2012)

Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia
por: Rishi, Pukhraj, et al.
Publicado: (2009)

Preliminary results of an intravitreal dexamethasone implant (Ozurdex®) in patients with persistent diabetic macular edema
por: Pacella, Elena, et al.
Publicado: (2013)

Choroidal thickness in normal Indian subjects using Swept source optical coherence tomography
por: Akhtar, Zeeshan, et al.
Publicado: (2018)

Foveal atrophy and macular hole formation following intravitreal ranibizumab with/without photodynamic therapy for choroidal neovascularization secondary to age-related macular degeneration
por: Rishi, Pukhraj, et al.
Publicado: (2011)

Five-Month Observation of Persistent Diabetic Macular Edema after Intravitreal Injection of Ozurdex Implant
por: Zalewski, Dominik, et al.
Publicado: (2014)

Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema
por: Castro-Navarro, Verónica, et al.
Publicado: (2019)

Intravitreal Injection of Ozurdex(®) Implant in Patients with Persistent Diabetic Macular Edema, with Six-Month Follow-Up
por: Pacella, Fernanda, et al.
Publicado: (2016)

Dexamethasone Intravitreal Implant (Ozurdex) for Long-Term Macular Edema after Epiretinal Membrane Peeling Surgery
por: Chang, Yo-Chen, et al.
Publicado: (2018)

Combined Phacoemulsification and Intravitreal Dexamethasone Implant (Ozurdex®) in Diabetic Patients with Coexisting Cataract and Diabetic Macular Edema
por: Furino, Claudio, et al.
Publicado: (2017)

Evaluation of the Effect of Intravitreal Dexamethasone (Ozurdex(®)) Implant on Intraocular Pressure in Vitrectomized and Non-Vitrectomized Eyes with Macular Edema
por: Garlı, Murat, et al.
Publicado: (2021)

Treatment of choroidal neovascularization in a case of factor VIII deficiency: Ten-year follow-up
por: Rishi, Pukhraj, et al.
Publicado: (2018)

Combined photodynamic therapy and intravitreal ranibizumab as primary treatment for choroidal neovascularization associated with age-related macular degeneration in an Indian patient
por: Rishi, Pukhraj, et al.
Publicado: (2008)

Combination photodynamic therapy and bevacizumab for choroidal neovascularization associated with toxoplasmosis
por: Rishi, Pukhraj, et al.
Publicado: (2011)

Results of intravitreal dexamethasone implant (Ozurdex(®)) for retinal vascular diseases with macular edema: An observational study of real-life situations
por: Jirarattanasopa, Pichai, et al.
Publicado: (2022)

Macular hole following successful stage 4B/stage 5 retinopathy of prematurity surgery
por: Rishi, Ekta, et al.
Publicado: (2019)

Photodynamic monotherapy or combination treatment with intravitreal triamcinolone acetonide, bevacizumab or ranibizumab for choroidal neovascularization associated with pathological myopia
por: Rishi, Pukhraj, et al.
Publicado: (2011)

Choroidal thickness in Waardenburg syndrome
por: Rishi, Pukhraj, et al.
Publicado: (2019)

Iatrogenic subretinal injection of Ozurdex(®) implant and its effect on macular edema
por: Karandikar, Smita Shriram, et al.
Publicado: (2017)

Spectral domain optical coherence tomography changes following intravitreal dexamethasone implant, Ozurdex(®) in patients with uveitic cystoid macular edema
por: Bansal, Pooja, et al.
Publicado: (2015)

Macular hole developing in a post-vitrectomized eye and its surgical outcome
por: Rishi, Pukhraj, et al.
Publicado: (2013)

Repeat gas insufflation for successful closure of idiopathic macular hole following failed primary surgery
por: Rishi, Pukhraj, et al.
Publicado: (2014)

Author response: Repeat gas insufflation for successful closure of idiopathic macular hole following failed primary surgery
por: Rishi, Pukhraj, et al.
Publicado: (2015)

Methoxsalen-induced macular toxicity
por: Maitray, Aditya, et al.
Publicado: (2017)

Influence of Intravitreal Therapy on Choroidal Thickness in Patients with Diabetic Macular Edema
por: Udaondo Mirete, Patricia, et al.
Publicado: (2023)

Macular Oedema Related to Idiopathic Macular Telangiectasia Type 1 Treated with Dexamethasone Intravitreal Implant (Ozurdex)
por: Loutfi, Mohamed, et al.
Publicado: (2014)

Retinal pigment epithelial changes after trypan blue-assisted internal limiting membrane peeling for idiopathic macular hole
por: Rishi, Pukhraj, et al.
Publicado: (2011)

Author's response Comments on Repeat gas insufflation for successful closure of idiopathic macular hole following failed primary surgery
por: Rishi, Pukhraj, et al.
Publicado: (2015)

PROLONGED OZURDEX-MACULAR CONTACT FOLLOWING VITRECTOMY FOR MACULAR HOLE
por: Kelkar, Aditya S., et al.
Publicado: (2019)

Retinal detachment with hemorrhagic intraretinal macrocyst clinically presenting as pseudo-choroidal melanoma
por: Naik, Anmol U., et al.
Publicado: (2019)

Delayed, spontaneous conversion of type 2 closure to type 1 closure following surgery for traumatic macular hole associated with submacular hemorrhage
por: Rishi, Pukhraj, et al.
Publicado: (2012)

Morphology and Function over a One-Year Follow Up Period after Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema
por: Mastropasqua, Rodolfo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5h4dqika82jhj6fp768qmet0s1